These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8426226)

  • 21. Tau protein and the neurofibrillary pathology of Alzheimer's disease.
    Goedert M
    Ann N Y Acad Sci; 1996 Jan; 777():121-31. PubMed ID: 8624074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in vitro formation of recombinant tau polymers: effect of phosphorylation and glycation.
    Ledesma MD; Medina M; Avila J
    Mol Chem Neuropathol; 1996 Apr; 27(3):249-58. PubMed ID: 9147411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofibrillary degeneration and microtubule associated protein tau.
    Yen SH; Liu WK
    Chin J Physiol; 1992; 35(4):357-66. PubMed ID: 1308732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microtubule depolymerization and tau phosphorylation.
    Hernández F; García-García E; Avila J
    J Alzheimers Dis; 2013; 37(3):507-13. PubMed ID: 23948896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
    Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of Microtubule Assembly by Tau and not by Pin1.
    Kutter S; Eichner T; Deaconescu AM; Kern D
    J Mol Biol; 2016 May; 428(9 Pt A):1742-59. PubMed ID: 26996940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathology of the neuronal cytoskeleton in Alzheimer's disease.
    Brion JP
    Biochim Biophys Acta; 1992 Nov; 1160(1):134-42. PubMed ID: 1384716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.
    Shin RW
    Gerontology; 1997; 43 Suppl 1():16-23. PubMed ID: 9187935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease.
    Bondareff W; Harrington CR; Wischik CM; Hauser DL; Roth M
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):657-63. PubMed ID: 7666054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau truncation is a productive posttranslational modification of neurofibrillary degeneration in Alzheimer's disease.
    Kovacech B; Novak M
    Curr Alzheimer Res; 2010 Dec; 7(8):708-16. PubMed ID: 20678071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles.
    Spillantini MG; Crowther RA; Goedert M
    Acta Neuropathol; 1996 Jul; 92(1):42-8. PubMed ID: 8811124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational change and GTPase activity of human tubulin: A comparative study on Alzheimer's disease and healthy brain.
    Rajaei S; Karima S; Sepasi Tehrani H; Shateri S; Mahmoodi Baram S; Mahdavi M; Mokhtari F; Alimohammadi A; Tafakhori A; Amiri A; Aghamollaii V; Fatemi H; Rajabibazl M; Kobarfard F; Gorji A
    J Neurochem; 2020 Sep; 155(2):207-224. PubMed ID: 32196663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformational change as one of the earliest alterations of tau in Alzheimer's disease.
    Weaver CL; Espinoza M; Kress Y; Davies P
    Neurobiol Aging; 2000; 21(5):719-27. PubMed ID: 11016541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orientation, assembly, and stability of microtubule bundles induced by a fragment of tau protein.
    Brandt R; Lee G
    Cell Motil Cytoskeleton; 1994; 28(2):143-54. PubMed ID: 8087873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microtubule assembly competence analysis of freshly-biopsied human tau, dephosphorylated tau, and Alzheimer tau.
    Garver TD; Lehman RA; Billingsley ML
    J Neurosci Res; 1996 Apr; 44(1):12-20. PubMed ID: 8926625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tau proteins and neurofibrillary degeneration.
    Goedert M; Spillantini MG; Crowther RA
    Brain Pathol; 1991 Jul; 1(4):279-86. PubMed ID: 1669718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3beta.
    Lin YT; Cheng JT; Liang LC; Ko CY; Lo YK; Lu PJ
    J Neurochem; 2007 Oct; 103(2):802-13. PubMed ID: 17680984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
    Keck S; Nitsch R; Grune T; Ullrich O
    J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tau glycation is involved in aggregation of the protein but not in the formation of filaments.
    Ledesma MD; Pérez M; Colaco C; Avila J
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1111-6. PubMed ID: 9846893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.